Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ABL1 | P00519 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | IDE | P14735 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | CA12 | O43570 | 6/20 | 0.63 |
| ▸ | CA1 | P00915 | 6/20 | 0.63 |
| ▸ | CA2 | P00918 | 6/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.63 |
| ▸ | HLCS | P50747 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565406 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL5585656 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL12424056 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL19514780 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL5585660 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL10140211 | 1.00 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL14812382 | 0.99 | TDP1 (0.70) | TDP1MEN1ABL1LMNAPKM | |
| Hydrazine SCHEMBL28140320 | 0.99 | TDP1 (0.70) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL23863708 | 0.96 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL1024507 | 0.94 | HLCS (0.72) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3148 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084901-A | Method for diagnosing prostate cancer by using exosome surface protein spectrum | — | 2026-05-26 | — | — | CN | claimed |
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026107515-A1 | INCRETIN HORMONE COMPOSITIONS AND METHODS USING SAME | DIASOME PHARMACEUTICALS, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260124139-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | DIASOME PHARMACEUTICALS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4703373-A1 | POLYPEPTIDES AND RELATED SUBSTANCES AGAINST HAIR LOSS AND DERMATITIS, AND USES THEREOF | Shenzhen Institutes of Advanced Technology (CN) | 2026-03-04 | — | — | EP | claimed |
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2025-09-18 | — | — | US | claimed |
| US-12332249-B1 | Biomolecule detection method using diffusion ordered spectroscopy | KUWAIT UNIVERSITY (KW) | 2025-06-17 | — | — | US | claimed |
| EP-4520766-A1 | OVARY-TARGETING POLYPEPTIDE, AND DERIVATIVE AND USE THEREOF | Shenzhen Institute of Advanced Technology Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | claimed |
| US-20250057911-A1 | OVARY-TARGETING POLYPEPTIDE, AND DERIVATIVE AND THE USE THEREOF | SHENZHEN INSTITUTES OF ADVANCEDTECHNOLOGY CHINESE ACADEMY OF SCIENCES (CN) | 2025-02-20 | — | — | US | claimed |
| WO-2025000474-A1 | POLYPEPTIDE FOR COUNTERACTING ALOPECIA AND DERMATITIS, AND RELATED SUBSTANCE AND USE THEREOF | 深圳先进技术研究院 | 2025-01-02 | — | — | WO | claimed |
| EP-0961833-A1 | HUMAN PLASMA HYALURONIDASE | The Regents of the University of California (US) | 1999-12-08 | — | — | EP | claimed |
| EP-0837869-A2 | METHOD FOR PRODUCING SYNTHETIC N-LINKED GLYCOCONJUGATES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1998-04-29 | — | — | EP | claimed |
| WO-1998016655-A1 | HUMAN PLASMA HYALURONIDASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-23 | — | — | WO | claimed |
| US-5668272-A | Method for producing synthetic N-linked glycoconjugates | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1997-09-16 | — | — | US | claimed |
| WO-1997002277-A2 | METHOD FOR PRODUCING SYNTHETIC N-LINKED GLYCOCONJUGATES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1997-01-23 | — | — | WO | claimed |
| EP-0088542-B1 | SKIN TREATMENT COMPOSITION | UNILEVER N.V. (NL) | 1988-05-11 | — | — | EP | claimed |
| EP-0256117-A1 | LATEX AGGLUTINATION USING AVIDIN/BIOTIN SYSTEM | MICROBIOLOGICAL ASSOCIATES, INC. (US) | 1988-02-24 | — | — | EP | claimed |
| WO-1987004794-A1 | LATEX AGGLUTINATION USING AVIDIN/BIOTIN SYSTEM | MICROBIOLOGICAL ASSOCIATES, INC. (US) | 1987-08-13 | — | — | WO | claimed |
| US-4529587-A | Using biotin antagonist | LEVER BROTHERS COMPANY (US) | 1985-07-16 | — | — | US | claimed |
| EP-0088542-A2 | Skin treatment composition | UNILEVER N.V. (NL) | 1983-09-14 | — | — | EP | claimed |